Analysed US Stem Cell Inc (USRM:OTCMKTS) News Sources
BrainStorm Cell Therapeutics Inc.: Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
FinanzNachrichten.de
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
Yahoo Finance
BioRestorative secures Australian patent protection for ThermoStem® obesity therapy platform
InvestorsHub on MSN
BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
Markets Insider
11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy
Markets Insider
VetStem Cell Therapy Improves Quality of Life in Great Pyrenees with Hip Arthritis
The Indianapolis Star
What is the current price of US Stem Cell Inc (USRM:OTCMKTS)?
The current price of US Stem Cell Inc (USRM:OTCMKTS) is $0.0001.
US Stem Cell Inc (USRM:OTCMKTS) absolute price change since previous trading day?
The absolute price change of US Stem Cell Inc (USRM:OTCMKTS) since the previous trading day is $0.00.
US Stem Cell Inc (USRM:OTCMKTS) percentage price change since previous trading day?
The percentage price change of US Stem Cell Inc (USRM:OTCMKTS) since the previous trading day is 0.00%.
What is This Week's average sentiment score for US Stem Cell Inc (USRM:OTCMKTS)?
This Week's average sentiment score for US Stem Cell Inc (USRM:OTCMKTS) is 78 out of 100.
What is This Week's average sentiment for US Stem Cell Inc (USRM:OTCMKTS)?
This Week's sentiment for US Stem Cell Inc (USRM:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.